Product Details

Avastin 100 mg**

Bevacizumab
100 mg/4 mL
Concentrate for solution for infusion

ROA

Intravenous

Applicant Name

Roche Products Limited

NRN

A6-0123

Status

Active


Composition

Each 4-mL multiple dose vial contains 100 mg Bevacizumab. Bevacizumab (manufactured by recombinant DNA technology using CHO [Chinese hamster ovary] cells) Excipient: Each mL of concentrate contains 1.35 mg Sodium, i.e. 5.42 mg or 21.67 mg per multiple dose vial  

ATC Code

L01FG01  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

4 mL x 1's (in single-dose vial)  

Product Description

Concentrate for solution for infusion in 4-mL single dose colourless glass vial. Clear to slightly opalescent, colourless to pale brown sterile fluid for intravenous infusion

Manufacturer Name

F. Hoffmann-La Roche Ltd

Manufacturer Country

SWITZERLAND  

Approval Date

2023-02-26  

Expiry Date

2028-02-22